Deciduous Therapeutics
About:
Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune modulatory therapies.
Website: https://www.deciduoustx.com/
Top Investors: Global Brain Corporation, 8VC, CRV, Bold Capital Partners, Presight Capital
Description:
Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune-modulatory therapies that clear senescent cells and promote a healthy lifespan. Deciduous is led by Anil Bhushan, a professor at UCSF, and Robin Mansukhani, a five-time biotech founder.
Total Funding Amount:
$16.5M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Francisco, California, United States
Founded Date:
2018-01-01
Founders:
Anil Bhushan, Robin Mansukhani
Number of Employees:
11-50
Last Funding Date:
2022-12-31
IPO Status:
Private
Industries:
© 2025 bioDAO.ai